UCB

UCB, Brussels, Belgium (www.ucb.com) is a global biopharmaceutical company focused on the discovery and development of innovative medicines and solutions to transform the lives of people living with severe diseases of the immune system or of the central nervous system. With more than 7 500 people operating in ~ 40 countries, the company generated revenue of € 4.9 billion in 2019. UCB is listed on Euronext Brussels .